Literature DB >> 23336543

Effectiveness of a treatment programme for immigrants who committed gender-based violence against their partners.

José Antonio Echauri1, Javier Fernández-Montalvo, María Martínez, Juana Ma Azkarate.   

Abstract

BACKGROUND: In recent years, the number of immigrant perpetrators who attend treatment programmes for partner violence has increased. In this study, the effectiveness of a psychological treatment programme for immigrant men who have committed a gender-based violent crime was evaluated.
METHODS: The sample was composed of 300 individuals (150 immigrants and 150 citizens) who received treatment in the batterer intervention programme developed in Pamplona (Navarra). A two-group design was used (immigrants and citizens) with multiple, repeated evaluations (pre-treatment, post-treatment, and 12-month follow-up).
RESULTS: Results showed the usefulness of the programme, with no statistically significant differences in the success and improvement rates observed between the immigrant and citizen patient groups. Post-treatment success rate was 34.6% both in the immigrant group and the citizen group. The improvement rate was 51.3% in both groups. Results at 12-month follow up were nearly the same. The combined rate of success and improvement was 87.3% among immigrants and 86.6% among citizens. In addition, the associated psychopathologic symptoms exhibited significant improvement.
CONCLUSIONS: The tested programme was shown to be effective in the treatment of immigrant batterers.

Entities:  

Mesh:

Year:  2013        PMID: 23336543     DOI: 10.7334/psicothema2012.75

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  1 in total

Review 1.  Interventions to reduce adverse health outcomes resulting from manifestations of gender bias amongst immigrant populations: a scoping review.

Authors:  Alia Januwalla; Ariel Pulver; Susitha Wanigaratne; Patricia O'Campo; Marcelo L Urquia
Journal:  BMC Womens Health       Date:  2018-06-19       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.